228 related articles for article (PubMed ID: 19344719)
1. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Wasmuth HE; Lammert F; Zaldivar MM; Weiskirchen R; Hellerbrand C; Scholten D; Berres ML; Zimmermann H; Streetz KL; Tacke F; Hillebrandt S; Schmitz P; Keppeler H; Berg T; Dahl E; Gassler N; Friedman SL; Trautwein C
Gastroenterology; 2009 Jul; 137(1):309-19, 319.e1-3. PubMed ID: 19344719
[TBL] [Abstract][Full Text] [Related]
2. Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.
Cripps JG; Celaj S; Burdick M; Strieter RM; Gorham JD
Lab Invest; 2012 Oct; 92(10):1461-71. PubMed ID: 22906987
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
4. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
5. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
[TBL] [Abstract][Full Text] [Related]
6. Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice.
Sahin H; Borkham-Kamphorst E; Kuppe C; Zaldivar MM; Grouls C; Al-samman M; Nellen A; Schmitz P; Heinrichs D; Berres ML; Doleschel D; Scholten D; Weiskirchen R; Moeller MJ; Kiessling F; Trautwein C; Wasmuth HE
Hepatology; 2012 May; 55(5):1610-9. PubMed ID: 22237831
[TBL] [Abstract][Full Text] [Related]
7. CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.
Hintermann E; Bayer M; Pfeilschifter JM; Luster AD; Christen U
J Autoimmun; 2010 Dec; 35(4):424-35. PubMed ID: 20932719
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.
Zeremski M; Petrovic LM; Chiriboga L; Brown QB; Yee HT; Kinkhabwala M; Jacobson IM; Dimova R; Markatou M; Talal AH
Hepatology; 2008 Nov; 48(5):1440-50. PubMed ID: 18798334
[TBL] [Abstract][Full Text] [Related]
9. Gene profile of chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9/10 on liver non-parenchymal cells.
Liang YJ; Luo J; Lu Q; Zhou Y; Wu HW; Zheng D; Ren YY; Sun KY; Wang Y; Zhang ZS
PLoS One; 2012; 7(8):e42490. PubMed ID: 22905138
[TBL] [Abstract][Full Text] [Related]
10. CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung.
Manicone AM; Burkhart KM; Lu B; Clark JG
Exp Lung Res; 2008 Sep; 34(7):391-407. PubMed ID: 18716926
[TBL] [Abstract][Full Text] [Related]
11. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
[TBL] [Abstract][Full Text] [Related]
12. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.
Shields PL; Morland CM; Salmon M; Qin S; Hubscher SG; Adams DH
J Immunol; 1999 Dec; 163(11):6236-43. PubMed ID: 10570316
[TBL] [Abstract][Full Text] [Related]
13. Enhanced T cell transmigration across the murine liver sinusoidal endothelium is mediated by transcytosis and surface presentation of chemokines.
Schrage A; Wechsung K; Neumann K; Schumann M; Schulzke JD; Engelhardt B; Zeitz M; Hamann A; Klugewitz K
Hepatology; 2008 Oct; 48(4):1262-72. PubMed ID: 18697212
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of Allergic Pulmonary Inflammation in CXCR3Knockout Mice Sensitized and Challenged with House Dust Mite Protein.
Liu Z; Chen H; Chen X; Gao J; Guo Z
PLoS One; 2016; 11(10):e0162905. PubMed ID: 27727269
[TBL] [Abstract][Full Text] [Related]
15. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.
Ohtani H; Jin Z; Takegawa S; Nakayama T; Yoshie O
J Pathol; 2009 Jan; 217(1):21-31. PubMed ID: 18980207
[TBL] [Abstract][Full Text] [Related]
16. Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1.
Schwarz JB; Langwieser N; Langwieser NN; Bek MJ; Seidl S; Eckstein HH; Lu B; Schömig A; Pavenstädt H; Zohlnhöfer D
Circ Res; 2009 Jan; 104(2):189-200. PubMed ID: 19059841
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines].
Wasmuth HE; Weiskirchen R
Z Gastroenterol; 2010 Jan; 48(1):38-45. PubMed ID: 20072995
[TBL] [Abstract][Full Text] [Related]
18. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
Wu X; Lahiri A; Haines GK; Flavell RA; Abraham C
J Immunol; 2014 Apr; 192(7):3409-18. PubMed ID: 24591373
[TBL] [Abstract][Full Text] [Related]
19. The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C.
Eisenhardt M; Glässner A; Krämer B; Körner C; Sibbing B; Kokordelis P; Nischalke HD; Sauerbruch T; Spengler U; Nattermann J
PLoS One; 2012; 7(7):e38846. PubMed ID: 22792160
[TBL] [Abstract][Full Text] [Related]
20. The chemokine receptor CXCR3 limits injury after acute toxic liver damage.
Zaldivar MM; Berres ML; Sahin H; Nellen A; Heinrichs D; Schmitz P; Gassler N; Streetz KL; Trautwein C; Wasmuth HE
Lab Invest; 2012 May; 92(5):724-34. PubMed ID: 22430509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
